Staphylococcus epidermidis is a common pathogen in device-associated infections which is able to attach onto polymeric surfaces and develop multilayered biofilms. Attached S. epidermidis displays reduced susceptibility to antimicrobial agents. In this study we investigated the influence of ciprofloxacin and the group IV quinolones gatifloxacin, gemifloxacin, and moxifloxacin with the minimal attachment killing (MAK) assay. MAK concentrations were determined for three biofilm-positive wild-type strains and their isogenic biofilm-negative mutants Depending on strain and investigated quinolone, it was possible to distinguish between a heterogeneous MAK (MAKhetero), and a homogeneous resistance (MAKhomo) which corresponds to the model of a few persisting cells under antibiotic treatment. A lower MAKhomo was detected for the biofilm-negative mutants as well as for the corresponding wild-types for some of the tested quinolones, which seems to be a result of higher bacterial inocula, whereas the MAKhetero concentrations were comparable for mutants and wild-types for nearly all of the tested antibiotics and strains. These data indicate that biofilm formation is not necessary for persistence of attached S. epidermidis cells under treatment with quinolones and could explain therapeutic failure in foreign body-associated infections due to biofilm-negative S. epidermidis isolates. The individual resistance phenotypes of investigated strains indicate that the determination of MAK concentrations might help to predict the therapy outcome of foreign body-associated infections with both biofilm-positive and biofilm-negative S. epidermidis. Thus, the relatively high activity displayed by group IV quinolones against individual attached staphylococcal isolates indicates a possible treatment option with the respective quinolones for foreign body-associated infections due to these isolates. (Int J Artif Organs 2008; 31: 752–60)
AmorenaB., GraciaE., MonzonM.Antibiotic susceptibility assay for Staphylococcus aureus in biofilms developed in vitro. J Antimicrob Chemother1999; 44: 43–55.
2.
AnderlJ.N., FranklinM J, StewartPS. Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother2000; 44: 1818–4.
3.
AnwarH., StrapJL, and CostertonJW. Eradication of biofilm cells of Staphylococcus aureus with tobramycin and cephalexin. Can J Microbiol1992; 38: 618–25.
4.
BaldassarriL., BertucciniL., AmmendoliaM.G., ArciolaC.R., MontanaroL.Effect of iron limitation on slime production by Staphylococcus aureus. Eur J Clin Microbiol Infect Dis2001; 20: 343–5.
5.
BerthaudN., DesnottesJ.F.In-vitro bactericidal activity of quinupristin/dalfopristin against adherent Staphylococcus aureus. J Antimicrob Chemother1997; 39(Suppl A): S99–102.
6.
CagniA., ChuardC., VaudauxP.E., SchrenzelJ., LewD.P.Comparison of sparfloxacin, temafloxacin, and ciprofloxacin for prophylaxis and treatment of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother1995; 39: 1655–60.
7.
CercaN., MartinsS., CercaF.Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry. J Antimicrob Chemother2005; 56: 331–6.
8.
ChristensenG.D., SimpsonW.A., BisnoA.L., BeacheyE.H.Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect Immun1982; 37: 318–26.
9.
Clinical and Laboratory Standards Institute M7-A7, Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standardWayne, PA: Clinical and Laboratory Standards Institute; 2006
10.
CostertonJ.W., StewartP.S., GreenbergE.P.Bacterial biofilms: a common cause of persistent infections. Science1999; 284: 1318–22.
11.
DuguidI.G., EvansE., BrownM.R., GilbertP.Effect of biofilm culture upon the susceptibility of Staphylococcus epidermidis to tobramycin. J Antimicrob Chemother1992; 30: 803–10.
12.
DunneW.M., MasonE.O., KaplanS.L.Diffusion of rifampin and vancomycin through a Staphylococcus epidermidis biofilm. Antimicrob Agents Chemother1993; 37: 2522–6.
13.
EspersenF., Frimodt-MollerN., CorneliussenL., ThamdrupR., SkinhojP.Experimental foreign body infection in mice. J Antimicrob Chemother1993; 31(Suppl D): S103–11.
14.
FarberB.F., KaplanM.H., ClogstonA.G.Staphylococcus epidermidis extracted slime inhibits the antimicrobial action of glycopeptide antibioticsJ Infect Dis1990; 161: 37–40.
15.
GötzF., PetersG.Colonization of Medical Devices by Coagulase-Negative Staphylococci. In: WaldvogelF.A., BisnoA.L. (eds). Infections Associated with Indwelling Medical Devices.Washington DC: ASM Press; 2000. p 55–88.
16.
Hamilton-MillerJ.M., ShahS.Activity of quinupristin/dalfopristin against Staphylococcus epidermidis in biofilms: a comparison with ciprofloxacin. J Antimicrob Chemother1997; 39(Suppl A): 103–8.
17.
HeilmannC., HussainM., PetersG., GötzF.Evidence for autolysin-mediated primary attachment of Staphylococcus epidermidis to a polystyrene surface. Mol Microbiol1997; 24: 1013–24.
18.
HerrmannM., VaudauxP.E., PittetD.Fibronectin, fibrinogen, and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material. J Infect Dis1988; 158: 693–701.
19.
IshidaH., IshidaY., KurosakaY., OtaniT., SatoK., KobayashiH.In vitro and in vivo activities of levofloxacin against bio-film-producing Pseudomonas aeruginosa. Antimicrob Agents Chemother1998; 42: 1641–5.
20.
JorgensenJ.H., TurnidgeJ.D., WashingtonJ.A.Antibacterial susceptibility tests: dilution and disk diffusion methods. In: MurrayP.R. (ed). Manual of Clinical Microbiology.Washington, DC: ASM Press; 1999. p 1526–43.
21.
KerenI., KaldaluN., SpoeringA., WangY., LewisK.Persister cells and tolerance to antimicrobials. FEMS Microbiol Lett2004; 230: 13–8.
22.
KnoblochJ.K., BartschtK., SabottkeA.Biofilm formation by Staphylococcus epidermidis depends on functional RsbU, an activator of the sigB operon: differential activation mechanisms due to ethanol and salt stress. J Bacteriol2001; 183: 2624–33.
23.
KnoblochJ.K., HorstkotteM.A., RohdeH., KaulfersP.M., MackD.Alcoholic ingredients in skin disinfectants increase biofilm expression of Staphylococcus epidermidis. J Antimicrob Chemother2002; 49: 683–7.
24.
KnoblochJ.K., NedelmannM., KielK.Establishment of an arbitrary PCR for rapid identification of Tn917 insertion sites in Staphylococcus epidermidis: characterization of bio-film-negative and nonmucoid mutants. Appl Environ Microbiol2003; 69: 5812–8.
25.
KnoblochJ.K., von OstenH., HorstkotteM.A., RohdeH., MackD.Minimal attachment killing (MAK): a versatile method for susceptibility testing of attached biofilm-positive and -negative Staphylococcus epidermidis. Med Microbiol Immunol (Berl)2002; 191: 107–14.
26.
KönigC., SchwankS., BlaserJ.Factors compromising antibiotic activity against biofilms of Staphylococcus epidermidis. Eur J Clin Microbiol Infect Dis2001; 20: 20–6.
27.
LewisK.Programmed death in bacteria. Microbiol Mol Biol Rev2000; 64: 503–14.
28.
LewisK.Riddle of biofilm resistance. Antimicrob Agents Chemother2001; 45: 999–1007.
MackD., HaederM., SiemssenN., LaufsR.Association of biofilm production of coagulase-negative staphylococci with expression of a specific polysaccharide intercellular adhesin. J Infect Dis1996; 174: 881–4.
33.
MackD., RiedewaldJ., RohdeH.Essential functional role of the polysaccharide intercellular adhesin of Staphylococcus epidermidis in hemagglutination. Infect Immun1999; 67: 1004–8.
34.
MackD., RohdeH., DobinskyS.Identification of three essential regulatory gene loci governing expression of Staphylococcus epidermidis polysaccharide intercellular adhesin and biofilm formation. Infect Immun2000; 68: 3799–807.
35.
MackD., RohdeH., HarrisL.G.Biofilm formation in medical device-related infection. Int J Artif Organs2006; 29: 343–59.
36.
MackD., SabottkeA., DobinskyS.Differential expression of methicillin resistance by different biofilm-negative Staphylococcus epidermidis transposon mutant classes. Antimicrob Agents Chemother2002; 46: 178–83.
37.
MackD., SiemssenN., LaufsR.Parallel induction by glucose of adherence and a polysaccharide antigen specific for plastic-adherent Staphylococcus epidermidis: evidence for functional relation to intercellular adhesion. Infect Immun1992; 60: 2048–57.
38.
MarrieT.J., NelliganJ., CostertonJ.W.A scanning and transmission electron microscopic study of an infected endocardial pacemaker lead. Circulation1982; 66: 1339–41.
39.
MontanaroL., CampocciaD., ArciolaC.R.Advancements in molecular epidemiology of implant infections and future perspectives. Biomaterials2007; 28: 5155–68.
40.
NedelmannM., SabottkeA., LaufsR., MackD.Generalized transduction for genetic linkage analysis and transfer of transposon insertions in different Staphylococcus epidermidis strains. Zentralbl Bakteriol1998; 287: 85–92.
41.
NilssonM., FrykbergL., FlockJ I.A fibrinogen-binding protein of Staphylococcus epidermidis. Infect Immun1998; 66: 2666–73.
42.
PascualA., FleerA., WesterdaalN.A., VerhoefJ.Modulation of adherence of coagulase-negative staphylococci to Teflon catheters in vitro. Eur J Clin Microbiol1986; 5: 518–22.
43.
PetersG., LocciR., PulvererG.Microbial colonization of prosthetic devices II. Scanning electron microscopy of naturally infected intravenous catheters. Zentralbl Bakteriol Mikrobiol Hyg [B]1981; 173: 293–9.
44.
RohdeH., BurandtE.C., SiemssenN.Polysaccharide intercellular adhesin or protein factors in biofilm accumulation of Staphylococcus epidermidis and Staphylococcus aureus isolated from prosthetic hip and knee joint infections. Biomaterials2007; 28: 1711–20.
45.
RuppM.E., FeyP.D., HeilmannC., GötzF.Characterization of the importance of Staphylococcus epidermidis autolysin and polysaccharide intercellular adhesin in the pathogenesis of intravascular catheter-associated infection in a rat model. J Infect Dis2001; 183: 1038–42.
46.
RuppM.E., UlphaniJ.S., FeyP.D., BartschtK., MackD.Characterization of the importance of polysaccharide intercellular adhesin/hemagglutinin of Staphylococcus epidermidis in the pathogenesis of biomaterial-based infection in a mouse foreign body infection model. Infect Immun1999; 67: 2627–32.
47.
RuppM.E., UlphaniJ.S., FeyP.D., MackD.Characterization of Staphylococcus epidermidis polysaccharide intercellular adhesin/hemagglutinin in the pathogenesis of intravascular catheter-associated infection in a rat model. Infect Immun1999; 67: 2656–9.
48.
SchaadH.J., ChuardC., VaudauxP.Comparative efficacies of imipenem, oxacillin and vancomycin for therapy of chronic foreign body infection due to methicillin-susceptible and -resistant Staphylococcus aureus. J Antimicrob Chemother1994; 33: 1191–200.
49.
SchaadH.J., ChuardC., VaudauxP., WaldvogelF.A., LewD.P.Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother1994; 38: 1703–10.
50.
SchierholzJ.M., BeuthJ., KönigD., NürnbergerA., PulvererG.Antimicrobial substances and effects on sessile bacteria. Zentralbl Bakteriol1999; 289: 165–77.
51.
SchwankS., RajacicZ., ZimmerliW., BlaserJ.Impact of bacterial biofilm formation on in vitro and in vivo activities of antibiotics. Antimicrob Agents Chemother1998; 42: 895–8.
52.
ShigetaM., TanakaG., KomatsuzawaH.Permeation of antimicrobial agents through Pseudomonas aeruginosa biofilms: a simple method. Chemotherapy1997; 43: 340–5.
53.
SteinA., DrancourtM., RaoultD.Ambulatory. Managment of Infected Orthopedic Implants. In: WaldvogelF.A., BisnoA.L. (eds). Infections Associated with Indwelling Medical Devices.Washington DC: ASM Press; 2000. p 211–230.
54.
TojoM., YamashitaN., GoldmannD.A., PierG.B.Isolation and characterization of a capsular polysaccharide adhesin from Staphylococcus epidermidis. J Infect Dis1988; 157: 713–22.
55.
VaudauxP.E., ZulianG., HugglerE., WaldvogelF.A.Attachment of Staphylococcus aureus to polymethyl methacrylate increases its resistance to phagocytosis in foreign body infection. Infect Immun1985; 50: 472–7.
56.
VeenstraG.J., CremersF.F., van DijkH., FleerA.Ultrastructural organization and regulation of a biomaterial adhesin of Staphylococcus epidermidis. J Bacteriol1996; 178: 537–41.
57.
VranyJ.D., StewartP.S., SuciP.A.Comparison of recalcitrance to ciprofloxacin and levofloxacin exhibited by Pseudomonas aeruginosa bofilms displaying rapid-transport characteristics. Antimicrob Agents Chemother1997; 41: 1352–8.
58.
WiederholdN.P., CoyleE.A., RaadI.I., PrinceR.A., LewisR.E.Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of gram-positive catheter-related bacteraemiaJ Antimicrob Chemother2005; 55: 792–5.
59.
YasudaH., AjikiY., KogaT., YokotaT.Interaction between clarithromycin and biofilms formed by Staphylococcus epidermidis. Antimicrob Agents Chemother1994; 38: 138–41.
60.
ZelverN., HamiltonM., PittsB.Measuring antimicrobial effects on biofilm bacteria: from laboratory to field. Methods Enzymol1999; 310: 608–28.
61.
ZhangS., SplendianiA., dos SantosL.M., LivingstonA.G.Determination of pollutant diffusion coefficients in naturally formed biofilms using a single tube extractive membrane bio-reactor. Biotechnol Bioeng1998; 59: 80–9.
62.
ZhengZ., StewartP.S.Penetration of rifampin through Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother2002; 46: 900–3.
63.
ZimmerliW., LewP.D., WaldvogelF.A.Pathogenesis of foreign body infection Evidence for a local granulocyte defect. J Clin Invest1984; 73: 1191–200.
64.
ZimmerliW., WidmerA.F., BlatterM.Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial Foreign-Body Infection (FBI) Study Group. JAMA1998; 279: 1537–41.
